Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 530

National Institutes of Health NIH

Illustrative image of a doctor comforting a patient with Alzheimer's Disease. (Chinnapong, iStock by Getty Images)
May 8, 2024, 10:24 pm
Study seeks to explain why Sephardi Jews more likely to get early-onset Alzheimer’s
NIH grants $13 million for genetic research after 2018 research showed Jews with roots in Spain, Middle East and North Africa see far more cases of early cognitive decline
By Renee Ghert-Zand
A Pluri employee at one of the company's bioreactors. (Courtesy)
September 5, 2023, 3:11 pm
Israel’s Pluri wins NIH contract for drug that could save lives in nuclear event
Company aims for FDA approval so that its novel cell therapy for radiation sickness can be eligible for US Strategic National Stockpile
By Renee Ghert-Zand
Illustrative: Vaccination in Rehovot, January 10, 2022 (Yossi Aloni/Flash90)
July 6, 2023, 5:59 pm
Sheba Pandemic Research Institute and partners developing pan-coronavirus vaccine
Researchers apply AI to unique database of healthcare workers’ blood samples to determine best antigen to protect against multiple pathogens and variants
By Renee Ghert-Zand
Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (left), receives the Champion of Global Human Health Award from Professor Yitshak Kreiss, director general of Sheba Medical Center, Washington, April 30, 2023. (Ron Sachs/CNP)
May 1, 2023, 4:51 pm
Sheba Medical Center presents Dr. Anthony Fauci with award for COVID cooperation
In one of his final acts as director of US infectious diseases institute, Fauci signed an agreement for joint research partnership utilizing Sheba’s unique blood sample bank
By Renee Ghert-Zand
US and Israeli researchers announce the formation of the Sheba Pandemic Research Institute (SPRI), December 22, 2022 (Courtesy Sheba Medical Center)
December 25, 2022, 2:35 pm
Israel’s Sheba Medical Center teams up with US health agency for pandemic research
Ramat Gan hospital to work with NIH for the quick identification of emerging pathogens and rapid deployment of scientific tools to fight them
By ToI Staff
Nancy Rose, who contracted COVID-19 in 2021 and continues to exhibit long-haul symptoms including brain fog and memory difficulties, pauses while organizing her desk space, in Port Jefferson, New York, Jan. 25, 2022. (John Minchillo/AP)
January 31, 2022, 1:55 pm
Omicron virus variant amps up concerns about long COVID and its causes
Researchers race to understand exactly what it is about the coronavirus that can keep some survivors suffering from a range of symptoms for a prolonged period
By laura ungar and Lindsey Tanner
SARS-CoV-2 virus particles, which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. (NIAID-RML via AP)
January 3, 2022, 12:41 pm
Study: Coronavirus spreads quickly throughout body, can linger in organs for months
US National Institutes of Health finds SARS-CoV-2 disseminates widely even in people who have asymptomatic illness
By ToI Staff
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks with reporters at the White House, in Washington, January 21, 2021 (AP Photo/Alex Brandon, File)
February 19, 2021, 1:09 pm
Fauci to ToI: Israeli vaccine effort ‘a model for rest of the world’
Top US infectious disease expert says Israel’s socialized health system eases distribution; urges PM not to let guard down if he chooses to declare victory once enough inoculated
By Jacob Magid
Illustrative: Courtney Senechal unpacks a special refrigerated box of Moderna COVID-19 vaccines as she prepared to ready more supply for use at the East Boston Neighborhood Health Center in Boston, Massachusetts, December 24, 2020. (Joseph Prezioso/AFP)
January 25, 2021, 5:34 pm
Moderna says its COVID-19 vaccine is effective against UK, South Africa variants
Biotech firm says it is nonetheless testing whether adding a second booster, to make 3 shots in total, could increase protection from new strains
By AFP and ToI Staff
Illustrative: In this March 16, 2020 file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)
July 27, 2020, 4:27 pm
US virus vaccine put to final test in thousands of volunteers
Shot developed by NIH and Moderna to be tried on 30,000 people in coming months, with Israel among countries rooting for its success
By AP and ToI Staff
Daniel Douek, a principal investigator at the National Institutes of Health (courtesy of Daniel Douek)
May 27, 2020, 11:48 pm
Fauci protégé sending gallons of Israeli blood to US to probe virus mysteries
Finding himself on sabbatical in Israel for the pandemic, Daniel Douek has ended up carving out an important role for the Jewish state in America’s battle against COVID-19
By Nathan Jeffay
Illustrative: Beds at a new coronavirus critical care unit at Sheba Medical Center (Courtesy)
April 23, 2020, 5:28 pm
Israel’s Sheba Medical and America’s NIH to join forces on COVID-19 research
Israel’s largest hospital will collaborate with the medical research agency of the US in studying virological and immunological aspects of the coronavirus
By Shoshanna Solomon
Hydroxychloroquine pills (AP Photo/John Locher)
April 22, 2020, 12:12 pm
Malaria drug stockpiled by Israel shows no benefit in virus treatment — study
US researchers report that a higher percentage of coronavirus patients given hydroxychloroquine died than those who received regular care
By AP and ToI Staff
Illustrative: A researcher with a vial in a lab, March 12, 2020, in Meriden, Connecticut, amidst researching a vaccine for COVID-19. (AP Photo/Jessica Hill)
March 16, 2020, 2:41 am
US government official: Coronavirus vaccine trial starts Monday
Tests on 45 young, healthy volunteers to begin in Washington state, but officials caution it will take a year to 18 months to fully validate any potential vaccine
By Zeke Miller
Tamar Pinto, who founded and runs the Gan Gurim preschool, teaching a student the Hebrew days of the week. (Ben Sales/JTA)
September 23, 2017, 3:36 am
This US preschool is so Israeli it may as well be Tel Aviv
At Gan Gurim, though many of the children were born in America, you’ll have trouble finding English child-rearing norms anywhere
By Ben Sales
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.